Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)

Abstract Background Aspirin is a key antiplatelet therapy for the prevention of thrombotic events in patients with cardiovascular disease. Studies suggest that ≈20% of patients with cardiac disease suffer from aspirin nonsensitivity, a phenomenon characterized by the inability of 81 mg aspirin to in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hamzah Khan, Abdelrahman Zamzam, Reid C. Gallant, Muzammil H. Syed, Margaret L. Rand, Heyu Ni, Thomas L. Forbes, Mohammed Al‐Omran, Mohammad Qadura
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2021-12-01
Edice:	Research and Practice in Thrombosis and Haemostasis
Témata:	antiplatelet aspirin blood platelets platelet aggregation thrombosis vascular diseases
On-line přístup:	https://doi.org/10.1002/rth2.12618
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!